Related references
Note: Only part of the references are listed.IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
Hyun-Woo Shin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Characteristics of IL-25 and allergen-induced airway fibrosis in a murine model of asthma
Xiujuan Yao et al.
RESPIROLOGY (2015)
LUNG DISEASE IL-25 blockade could reduce virus-associated asthma attacks
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2014)
Aggravation of atopic dermatitis-like symptoms by consecutive low concentration of formaldehyde exposure in NC/Nga mice
Ji-Yun Kim et al.
EXPERIMENTAL DERMATOLOGY (2013)
IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction
Jillian L. Barlow et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Macrophages as IL-25/IL-33-Responsive Cells Play an Important Role in the Induction of Type 2 Immunity
Zhonghan Yang et al.
PLOS ONE (2013)
IL-25 drives remodelling in allergic airways disease induced by house dust mite
Lisa G. Gregory et al.
THORAX (2013)
Prolonged Injury and Altered Lung Function after Ozone Inhalation in Mice with Chronic Lung Inflammation
Angela M. Groves et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
IL-17A and IL-25: therapeutic targets for allergic and exacerbated asthmatic disease
Bryan C. Petersen et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13
Ana Camelo et al.
JOURNAL OF GASTROENTEROLOGY (2012)
A self-assessment survey of the Institutional Animal Care and Use Committee, Part 1: animal welfare and protocol compliance
Jerald Silverman et al.
LAB ANIMAL (2012)
New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma
Gerard E. Kaiko et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Nuocytes: expanding the innate cell repertoire in type-2 immunity
Jillian L. Barlow et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Chronic inflammation and asthma
Jenna R. Murdoch et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Kazuyo Moro et al.
NATURE (2010)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Daniel R. Neill et al.
NATURE (2010)
Systemically dispersed innate IL-13-expressing cells in type 2 immunity
April E. Price et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Innate immune cell populations function as initiators and effectors in Th2 cytokine responses
Steven A. Saenz et al.
TRENDS IN IMMUNOLOGY (2010)
Induction of Airway Hyperreactivity by IL-25 Is Dependent on a Subset of Invariant NKT Cells Expressing IL-17RB
Philippe Stock et al.
JOURNAL OF IMMUNOLOGY (2009)
A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity
Asuka Terashima et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells
Yui-Hsi Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Interleukin 25 promotes the initiation of proallergic type 2 responses
Pornpimon Angkasekwinai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Interleukin-25 and interieukin-13 production by alveolar macrophages in response to particles
CM Kang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Mast cells produce interleukin-25 upon FcεRI-mediated activation
K Ikeda et al.
BLOOD (2003)
New IL-17 family members promote Th1 or Th2 responses in the lung: In vivo function of the novel cytokine IL-25
SD Hurst et al.
JOURNAL OF IMMUNOLOGY (2002)
IL-25 induces IL-4 IL-5, and IL-13 and Th2-associated pathologies in vivo
MM Fort et al.
IMMUNITY (2001)
Th2 cytokines and asthma: an introduction
PJ Barnes
RESPIRATORY RESEARCH (2001)